DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1992-2002

  Forns, Xavier ^a   Emerson, Suzanne U ^a   Tobin, Gregory J ^b   Mushahwar, Isa K ^c   Purcell, Robert H ^a   Bukh, Jens ^a  

^a Division of Viral Products   (United States)

^b SAIC FREDERICK INC   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

DNA vaccine; Hepatitis C virus; Non human primates; Surface expressed E2

Indexed keywords

ENVELOPE PROTEIN; PLASMID DNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; GENE THERAPY; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; MACACA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VIRUS ENVELOPE; VIRUS IMMUNITY;

ANIMALS; ANTIBODIES, VIRAL; BIOLISTICS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPACIVIRUS; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MACACA; MALE; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT PROTEINS; TRANSFECTION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0033537880     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00448-4     Document Type: Article

References (56)

1. Houghton M. Hepatitis C viruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology, vol. 1. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1996. p. 1035-58.
2. World Health Organization Hepatitis C: global prevalence. Weekly Epidemiol. Rec. 72:1997;341-348.
3. Bukh J., Purcell R.H., Miller R.H. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc. Natl. Acad. Sci. USA. 90:1993;8234-8238.
4. Okamoto H., Kurai K., Okada S.-I., Yamamoto K., Lizuka H., Tanaka T., Fukuda S., Tsuda F., Mishiro S. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology. 188:1992;331-341.
5. Okamoto H., Kojima M., Okada S.I., Yoshizawa H., Iizuka H., Tanaka T., Muchmore E.E., Peterson D.A., Ito Y., Mishiro S. Genetic drift of hepatitis-C virus during an 8.2-year infection in a chimpanzee - Variability and stability. Virology. 190:1992;894-899.
6. Tokita H., Okamoto H., Iizuka H., Kishimoto J., Tsuda F., Lesmana L.A., Miyakawa Y., Mayumi M.J. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. Gen. Virol. 77:1996;293-301.
7. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., Shimothono K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175:1991;220-228.
8. Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.-L., Houghton M., Han J.H. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 180:1991;842-848.
9. Rice CM. Flaviviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Virology, vol. 1. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1996. p. 931-60.
10. Farci P., Alter H.J., Govindarajan S., Wong D.C., Engle R., Lesniewski R.R., Mushahwar I.K., Desai S.M., Miller R.H., Ogata N., Purcell R.H. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
11. Lai M.E., Mazzoleni A.P., Argiolu F., De Virgilis S., Balestrieri A., Purcell R.H., Farci P. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 343:1994;388-390.
12. Farci P., Alter H.J., Wong D., Miller R.H., Govindarajan S., Engle R., Shapiro M., Purcell R.H. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA. 91:1994;7792-7796.
13. Shimizu Y.K., Hijikata M., Iwamoto A., Alter H.J., Purcell R.H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1994;1494-1500.
14. Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H.J., Purcell R.H. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA. 93:1996;15394-15399.
15. Shimizu Y.K., Igarashi H., Kiyohara T., Cabezon T., Farci P., Purcell R.H., Yoshikura H. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology. 223:1996;409-412.
16. Krawczynski K., Alter M.J., Tankersley D.L., Beach M., Robertson B.H., Lambert S., Kuo G., Spelbring J.E., Meeks E., Sinha S., Carson D.A. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J. Infect. Dis. 173:1996;822-828.
17. Choo Q.-L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C., Kansopon J., McFarland J., Tabrizi A., Ching K., Moss B., Cumminis L.B., Houghton M., Muchmore E. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 91:1994;1294-1298.
18. Houghton M, Choo Q-L, Chien D, Kuo G, Weiner A, Coates S, Cousens L, Wininger M, Selby M, Ralston R, Berger K, Dong C, Crawford K, Kansopon O, Chin M, Wong S, Tabrizi-Wright A, Purcell RH, Muchmore E, Morandi P, Rosa D, Abrignani S. Development of an HCV vaccine. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Turin: Minerva Medica, 1997. p. 656-9.
19. Weiner A.J., Geysen H.M., Christopherson C., Hall J.E., Mason T.J., Saracco G., Bonino F., Crawford K., Marion C.D., Crawford K.A., Brunetto M., Barr P.J., Miyamura T., McHutchinson J., Houghton M. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA. 89:1992;3468-3472.
20. Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Sem. Liver Dis. 15:1995;41-63.
21. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
22. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A.I., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90:1993;4156-4160.
23. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 91:1994;9866-9870.
24. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C.J. Vaccination with a plamid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
25. Michel M.L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA. 92:1995;5307-5311.
26. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science. 270:1995;299-302.
27. Bourne N., Stanberry L.R., Bernstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:1996;800-807.
28. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med. 3:1997;526-532.
29. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:1997;9563-9569.
30. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today. 19:1998;89-97.
31. Major M.E., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trepo C., Inchauspe G. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:1995;5798-5805.
32. Tokushige K., Wakita T., Pachuk C., Morapour D., Weiner D.B., Zurawski V.R., Wands J.R. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology. 24:1996;14-20.
33. Inchauspe G., Major M.E., Nakano I., Vitvitski L., Trepo C. DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine. 15:1997;853-856.
34. Lagging L.M., Meyer K., Hoft D., Houghton M., Belshe R.B., Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:1995;5859-5863.
35. Nakano I., Maertens G., Major M.E., Vitvitski L., Dubuisson J., Fournillier A., De Martynoff G., Trepo C., Inchauspe G. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J. Virol. 71:1997;7101-7109.
36. Saito T., Sherman G.J., Kurokohchi K., Guo Z.-P., Donets M., Yu M.-Y.W., Berzofsky J.A., Akatsuka T., Feinstone S.M. Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology. 112:1997;1321-1330.
37. Feinstone S.M., Alter H.J., Dienes H.P., Shimizu Y., Popper H., Blackmore D., Sly D., London W.T., Purcell R.H. Non-A, non-B hepatitis in chimpanzees and marmosets. J. Infect. Dis. 144:1981;588-598.
38. Yanagi M., Purcell R.H., Emerson S.U., Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA. 94:1997;8738-8743.
39. Forns X., Bukh J., Purcell R.H., Emerson S.U. How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure. Proc. Natl. Acad. Sci. USA. 94:1997;13909-13914.
40. Cocquerel L., Meunier J.-C., Pillez A., Wychowski C., Dubuisson J. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J. Virol. 72:1998;2183-2191.
41. Lesniewski R., Okasinski G., Carrick R., Van Sant C., Desai S., Johnson R., Scheffel J., Moore B., Mushahwar I. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J. Med. Virol. 45:1995;415-422.
42. Cerino A., Bissolati M., Cividini A., Nicosia A., Esumi M., Hayashi N., Mizuno K., Slobbe R., Oudshoorn P., Silini E., Asti M., Mondelli M.U. Antibody responses to the hepatitis C virus E2 protein: Relationship to viraemia and prevalence in anti-HCV seronegative subjects. J. Med. Virol. 51:1997;1-5.
43. Hussy P., Faust H., Wagner J.C., Scmid G., Mous J., Jacobsen H. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening. J. Hepatol. 26:1997;1179-1186.
44. Lee K.J., Suh Y.A., Cho Y.G., Cho Y.S., Ha G.W., Chung K.H., Hwang J.H., Yun Y.D., Lee D.S., Kim C.M., Sung Y.C. Hepatitis C virus E2 protein purified from mammalian cells is frequently recognized by E2-specific antibodies in patient sera. J. Biol. Chem. 272:1997;30040-30046.
45. Selby M.J., Glazer E., Masiarz F., Houghton M. Complex processing and protein:protein interactions in the E2-NS2 region of HCV. Virology. 204:1994;114-122.
46. Tedeschi V., Akatsuka T., Shih J.W.-K., Battegay M., Feinstone S.M. A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2. Hepatology. 25:1997;459-462.
47. Zibert A., Meisel H., Kraas W., Schulz A., Jung G., Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology. 25:1997;1245-1249.
48. De Franco AL. B-lymphocyte activation. In: Paul WE, editor. Fundamental immunology. 3rd ed. New York: Raven Press, 1993. p. 505-30.
49. Leclerc C., Charbit A., Martineau P., Deriaud E., Hofnung M. The cellular location of a foreign B-cell epitope expressed by recombinant bacteria determines its T-cell-independent or T-cell-dependent characteristics. J. Immunol. 147:1991;3545-3552.
50. Haddad D., Liljeqvist S., Kumar S., Hansson M., Ståhl S., Perlmann H., Perlmann P., Berzins K., Ahlborg N. Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity. FEMS Immunol. Med. Microbiol. 12:1995;175-186.
51. Srinivasan J., Singh O.M., Chakrabarti S., Talwar G.P. Targeting vaccinia virus-expressed secretory β subunit of human chorionic gonadotropin to the cell surface induces antibodies. Infect. Immun. 63:1995;4907-4911.
52. Men R., Bray M., Lai C.-J. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. J. Virol. 65:1991;1400-1407.
53. Doms R.W., Lamb R.A., Rose J.K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 193:1993;545-562.
54. Yi M., Nakamoto Y., Kaneko S., Yamashita T., Murakami S. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2. Virology. 231:1997;119-129.
55. Mink M.A., Benichou S., Madaule P., Tiollais P., Prince A.M., Inchauspe G. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology. 200:1994;246-255.
56. Davis H.L., McCluskie M.J., Gerin J.L., Purcell R.H. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA. 93:1996;7213-7218.